NASD · Healthcare · Medical Devices · USA
GE HealthCare Technologies Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Devices industry.
GE HealthCare Technologies Inc provides medical devices, pharmaceutical diagnostics, and AI-enabled cloud and software solutions to healthcare institutions globally. The company operates through four segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics, serving hospitals, health systems, and researchers worldwide.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the GE HealthCare Technologies Inc stock.
Slightly undervalued: intrinsic value $79.87 per share, market price $69.76, margin of safety 12.7% (as of 2026-10-19).
Discounting its cash flows at 8.4% (average of 3 methods) values the shares at $79.87; the price of $69.76 is 13% below that value, and 78% of that value comes from beyond year five.
Leak Score: 43/100 on 8 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
9 more in this industry show a wider margin of safety.
GEHC is slightly undervalued (as of the 2026-10-19 close). Discounting its cash flows at 8.4% (average of 3 methods) values the shares at $79.87; the price of $69.76 is 13% below that value, and 78% of that value comes from beyond year five.
$79.87 per share (as of the 2026-10-19 close), against a market price of $69.76. That is a margin of safety of 12.7%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
43 out of 100, which we rate "On Watch", on 8 of 12 value investing signals.